Insider and congress filings

HCA Healthcare, Inc. (HCA)

NYSE · Healthcare · 337 insider transactions · 90 congress trades · last filed 2 months agoS&P 500

5
Open-market insider filings shown
1d
Median delay on the insider filings, in business days
within the two business day rule
0 buys·5 sells
Purchases and sales in the filings shown
Get a push when an insider at HCA Healthcare, Inc. trades.

Free on iOS and Android.

About HCA Healthcare, Inc.

from the company's filings and listing, as of Oct 27, 2026
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Care Facilities
Chief executive
Samuel N. Hazen
Employees
320,000
Listed since
Mar 10, 2011
Market value
$100.7B
Price to earnings (12 mo)
15.5
Net income per share, as reported (12 mo)
$30.70
Dividend yield
0.66%

www.hcahealthcare.com

Earnings

6 reported quarters · next on Oct 27, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 24, 2026$7.59$7.56$20.2B$19.8BEPS in lineRevenue beat
Q1 FY2026reported Apr 24, 2026$7.15$7.12$19.1B$19.1BEPS in lineRevenue in line
Q4 FY2025reported Jan 27, 2026$8.01$7.46$19.5B$19.7BEPS beatRevenue in line
Q3 FY2025reported Oct 24, 2025$6.96$5.79$19.2B$18.6BEPS beatRevenue beat
Q2 FY2025reported Jul 25, 2025$6.84$6.29$18.6B$18.5BEPS beatRevenue in line
Q1 FY2025reported Apr 25, 2025$6.45$5.75$18.3B$18.3BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2025 · proxy filed Mar 13, 2026
ExecutiveSalaryStock awardsOtherTotal
Samuel N. HazenChief Executive Officer$1.6M$8.5M$16.4M$26.5M
Jon M. FosterExecutive Vice President and Chief Operating Officer$1.0M$1.9M$8.0M$11.0M
Michael A. MarksExecutive Vice President and Chief Financial Officer$983K$1.8M$7.6M$10.4M
Michael R. McAleveyExecutive Vice President - Chief Legal and Administrative Officer$1.0M$1.3M$3.4M$5.7M
Michael S. Cuffe, M.D.Executive Vice President and Chief Clinical Officer$975K$1.3M$3.5M$5.7M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$5.1B13,003,600-2.7%5.84%
Vanguard Capital Management LLC$4.0B10,141,708-0.4%4.55%
Sanders Capital, LLC$3.4B8,828,287-1.4%3.96%
State Street Corp$2.9B7,469,035-0.9%3.35%
Wellington Management Group LLP$1.8B4,707,473+20.5%2.11%
Geode Capital Management, LLC$1.4B3,668,008-0.7%1.65%
First Eagle Investment Management, LLC$1.3B3,295,565+1.3%1.48%
Vanguard Portfolio Management LLC$1.1B2,712,828-1.6%1.22%
Morgan Stanley$1.0B2,586,771+12.7%1.16%
Goldman Sachs Group Inc$960.8M2,464,314+15.4%1.11%
JPMorgan Chase & Co.$896.8M2,285,832-7.2%1.03%
Arrowstreet Capital, Limited Partnership$861.5M2,209,485+2.0%0.99%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Tracked fund managers holding HCA

4 managers
ManagerValueSharesShare of book
Darsana Capital Partners$428.9M1,100,0001.9%
Pentwater Capital Management$50.7M130,0000.3%
Element Capital Management$5.0M12,9000.2%
Brave Warrior Advisors$1.9M4,833n/a

4 of the 97 fund managers we track list HCA shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

Know when the next HCA filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

5 filings shown · newest filing first
InsiderActionSharesPriceValueTrade dateDelay
(business days)
Michael R. McAleveyEVP & Chief Legal & Admin Off.Sold1,694$533.37$904KFeb 18, 2026filed Feb 18, 20260d
Jennifer BerresSVP & Chief Human Res. OfficerSold4,010$503.00$2.0MFeb 11, 2026filed Feb 12, 20261d
Christopher F. WyattSVP & ControllerSold4,000$505.00$2.0MFeb 11, 2026filed Feb 12, 20261d
Michael S. CuffeEVP and Chief Clinical OfficerSold1,500$498.09$747KFeb 3, 2026filed Feb 5, 20262d
Samuel N. HazenCEOSold · 7 lines42,877$501.04$21.5MFeb 3, 2026filed Feb 5, 20262d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
Michael J. SchlosserEVP and Chief Clinical OfficerOther Form 4 entry (see filing)40,712Sep 1, 2026
Michael R. McAleveyEVP & Chief Legal & Admin Off.Other (see filing)7,769Aug 26, 2026
Mike A. MarksEVP and CFOGift3,336May 7, 2026
John ChidseyDirectorStock award809Apr 28, 2026
Nancy Ann DeparleDirectorStock award509Apr 28, 2026
Hugh F. JohnstonDirectorStock award809Apr 28, 2026
Michael W. MichelsonDirectorStock award925Apr 28, 2026
Wayne Joseph RileyDirectorStock award509Apr 28, 2026
Andrea B. SmithDirectorStock award509Apr 28, 2026
Thomas F. Frist IIIDirectorStock award1,041Apr 28, 2026
William R. FristDirectorStock award809Apr 28, 2026
Michael R. McAleveyEVP & Chief Legal & Admin Off.Tax withholding3,306Feb 13, 2026
Michael R. McAleveyEVP & Chief Legal & Admin Off.Option exercise5,000Feb 13, 2026
Jennifer BerresSVP & Chief Human Res. OfficerTax withholding2,515Feb 10, 2026
Jennifer BerresSVP & Chief Human Res. OfficerStock award7,116Feb 10, 2026
Michael S. CuffeEVP and Chief Clinical OfficerTax withholding3,501Feb 10, 2026
Michael S. CuffeEVP and Chief Clinical OfficerStock award9,628Feb 10, 2026
Jon M. FosterEVP and COOTax withholding5,888Feb 10, 2026
Jon M. FosterEVP and COOStock award15,696Feb 10, 2026
Samuel N. HazenCEOTax withholding21,323Feb 10, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Congress trades in HCA

20 disclosures of 90 on record · median 30d of the 45 allowed

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+26.6% since the tradeEstimated entry price $370.42, close on Mon Jul 20Current price $469.03, close on Fri Oct 23Jul 20, 2026Aug 7, 202618d
Jared MoskowitzDependent childStockPurchase$1,001 - $15,000+20.8% since the tradeEstimated entry price $388.16, close on Wed Jun 17Current price $469.03, close on Fri Oct 23Jun 17, 2026Jul 26, 202639d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000-0.6% since the tradeEstimated entry price $471.85, close on Fri Mar 27Current price $469.03, close on Fri Oct 23Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockSale$1,001 - $15,000+10.9% since the saleEstimated exit price $423.00, close on Fri May 15Current price $469.03, close on Fri Oct 23May 15, 2026Jun 9, 202625d
Ro KhannaStockSale$1,001 - $15,000+0.3% since the saleEstimated exit price $467.83, close on Mon Mar 30Current price $469.03, close on Fri Oct 23Mar 30, 2026Apr 7, 20268d
Ro KhannaStockSale$15,001 - $50,000-12.3% since the saleEstimated exit price $534.78, close on Tue Feb 17Current price $469.03, close on Fri Oct 23Feb 17, 2026Mar 9, 202620d
Ro KhannaStockSale$1,001 - $15,000+0.3% since the saleEstimated exit price $467.86, close on Mon Oct 27, 2025Current price $469.03, close on Fri Oct 23Oct 27, 2025Nov 6, 202510d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+16.4% since the saleEstimated exit price $402.85, close on Thu Sep 11, 2025Current price $469.03, close on Fri Oct 23Sep 11, 2025Oct 22, 202541d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+16.5% since the tradeEstimated entry price $402.69, close on Tue Aug 19, 2025Current price $469.03, close on Fri Oct 23Aug 19, 2025Sep 12, 202524d
Val T. HoyleSpouseStockPurchase$1,001 - $15,000+30.0% since the tradeEstimated entry price $360.67, close on Tue Oct 29, 2024Current price $469.03, close on Fri Oct 23Oct 29, 2024Sep 12, 2025318d
Val T. HoyleSpouseStockSale$1,001 - $15,000+55.0% since the saleEstimated exit price $302.52, close on Fri Dec 27, 2024Current price $469.03, close on Fri Oct 23Dec 27, 2024Sep 12, 2025259d
Jared MoskowitzDependent childStockPurchase$1,001 - $15,000+21.7% since the tradeEstimated entry price $385.50, close on Thu May 15, 2025Current price $469.03, close on Fri Oct 23May 15, 2025Jun 27, 202543d
Ro KhannaStockSale$1,001 - $15,000+29.9% since the saleEstimated exit price $360.98, close on Wed May 7, 2025Current price $469.03, close on Fri Oct 23May 7, 2025Jun 10, 202534d
Ro KhannaStockSale$15,001 - $50,000+29.9% since the saleEstimated exit price $360.98, close on Wed May 7, 2025Current price $469.03, close on Fri Oct 23May 7, 2025Jun 10, 202534d
Julie JohnsonJointStockSale$1,001 - $15,000+42.3% since the saleEstimated exit price $329.63, close on Mon Apr 7, 2025Current price $469.03, close on Fri Oct 23Apr 7, 2025May 14, 202537d
Ro KhannaStockPurchase$1,001 - $15,000+49.9% since the tradeEstimated entry price $312.87, close on Wed Mar 12, 2025Current price $469.03, close on Fri Oct 23Mar 12, 2025Apr 10, 202529d
Robert BresnahanStockSale$1,001 - $15,000+40.8% since the saleEstimated exit price $333.07, close on Tue Feb 25, 2025Current price $469.03, close on Fri Oct 23Feb 25, 2025Mar 27, 202530d
Ro KhannaStockPurchase$1,001 - $15,000+40.8% since the tradeEstimated entry price $333.07, close on Tue Feb 25, 2025Current price $469.03, close on Fri Oct 23Feb 25, 2025Mar 6, 20259d
Ro KhannaStockPurchase$1,001 - $15,000+51.1% since the tradeEstimated entry price $310.45, close on Fri Jan 17, 2025Current price $469.03, close on Fri Oct 23Jan 17, 2025Feb 6, 202520d
Ro KhannaStockSale$1,001 - $15,000+46.8% since the saleEstimated exit price $319.51, close on Wed Jan 22, 2025Current price $469.03, close on Fri Oct 23Jan 22, 2025Feb 6, 202515d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in HCA, filterable by party, chamber, type and account.

Members of Congress reporting a position

6 members · estimate, as of Oct 21, 2026

6 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Jared MoskowitzDemocrat · House$15,001 - $50,0000.7%
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%
Jimmy PatronisRepublican · House$15,001 - $50,0001.7%
Lucy McBathDemocrat · House$15,001 - $50,0000.3%
Robert BresnahanRepublican · House$15,001 - $50,0000.1%
Cliff BentzRepublican · House$1,001 - $15,0000.5%

Estimate, as of Oct 21, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Are insiders buying or selling HCA?

Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales.

Which members of Congress have traded HCA?

Ro Khanna, Jared Moskowitz, Alan Armstrong, Lisa C. McClain, Val T. Hoyle, Julie Johnson and others disclosed HCA transactions in the filings shown here.

Which members of Congress hold HCA?

6 members of Congress report a position in HCA in the estimate we hold as of Oct 21, 2026. The largest estimated positions, in the $15,001 - $50,000 band, include Jared Moskowitz, Gilbert Ray Cisneros, Jr. and Jimmy Patronis. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is HCA in the S&P 500 or the Nasdaq 100?

HCA Healthcare, Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 27, 2026. Current members of either index get a page here whatever their filing history.

How quickly are HCA trades disclosed?

Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 27, 2026.

Related companies

traded by the same members

See every company we track